Search Results - "Monzón, Tania"

Refine Results
  1. 1

    Efficacy and Safety of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist in Real-Life: A Case Series of Patients in Maintenance Incremental Hemodialysis by De la Flor, José C., Lorenzo, Javier Deira, Marschall, Alexander, Valga, Francisco, Vázquez, Tania Monzón, Cícero, Elisa Ruiz

    Published in Case reports in nephrology and dialysis (22-11-2022)
    “…The glucagon-like peptide-1 receptor agonists (GLP-1RA) are among the newest treatment options available for managing of type 2 diabetes mellitus and slowing…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Inflammation and hemodialysis adequacy: are C-reactive protein levels influenced by the dose of dialysis? by Valga, Francisco, Monzón, Tania, Vega-Diaz, Nicanor, Rodriguez-Perez, José Carlos, Ruiz-Santana, Sergio

    Published in Nefrología (01-03-2022)
    “…Chronic inflammation and the underlying cardiovascular comorbidity are still current problems in chronic hemodialysis patients. There are few studies comparing…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios as markers of erythropoietin resistance in chronic haemodialysis patients: A multicentre cross-sectional study by Valga, Francisco, Monzón, Tania, Henriquez, Fernando, Santana-del-Pino, Angelo, Antón-Pérez, Gloria

    Published in Nefrología (01-05-2020)
    “…The platelet-to-lymphocyte (PLR) and neutrophil-to-lymphocyte (NLR) ratios are emerging markers of inflammation. Erythropoietin resistance is associated with…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Inflamación y adecuación de la hemodiálisis: ¿están los niveles de proteína C reactiva influidos por la dosis de diálisis recibida? by Valga, Francisco, Monzón, Tania, Vega-Diaz, Nicanor, Rodriguez-Perez, José Carlos, Ruiz-Santana, Sergio

    Published in Nefrología (01-03-2022)
    “…La inflamación crónica y la subyacente comorbilidad cardiovascular aún son problemas vigentes en los pacientes en hemodiálisis crónica. Existen pocos estudios…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Índices plaquetas-linfocito y neutrófilo-linfocito como marcadores de resistencia a la eritropoyetina en pacientes en hemodiálisis crónica: estudio transversal-multicéntrico by Valga, Francisco, Monzón, Tania, Henriquez, Fernando, Santana-del-Pino, Angelo, Antón-Pérez, Gloria

    Published in Nefrología (01-05-2020)
    “…Los índices plaquetas-linfocito (IPL) y neutrófilo-linfocito (INL) son marcadores emergentes de inflamación. La resistencia a la eritropoyetina está…”
    Get full text
    Journal Article
  19. 19
  20. 20